Polychlorinated biphenyl (PCB) induction of CYP3A4 enzyme activity in healthy Faroese adults

被引:21
|
作者
Petersen, Maria Skaalum
Halling, Jonrit
Damkier, Per
Nielsen, Flemming
Grandjean, Philippe
Weihe, Pal
Brosen, Kim
机构
[1] Univ So Denmark, Inst Publ Hlth Environm Med, DK-5000 Odense C, Denmark
[2] Univ So Denmark, Inst Publ Hlth Clin Pharmacol, DK-5000 Odense C, Denmark
[3] Odense Univ Hosp, Dept Biochem Pharmacol & Genet, DK-5000 Odense, Denmark
[4] Faroese Hosp Syst, Dept Occupat & Publ Hlth, FR-100 Torshavn, Faroe Islands, Denmark
[5] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA
关键词
CYP3A4; 6 beta-hydroxycortisol/cortisol ratio; polychlorinated biphenyls; persistent organohalogen pollutants; Faroe islands;
D O I
10.1016/j.taap.2007.07.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The CYP3A4 enzyme is, along with other cytochrome P450 enzymes, involved in the metabolism of environmental pollutants and is highly inducible by these substances. A commercial polychlorinated biphenyl (PCB) mixture, 1,1,1,-trichloro-2-(o-chlorophenyl), 2-(p'-chlorophenyl) ethane (o,p'-DDT) and 1,1,-dichloro-2,2-bis (p-chlorophenyl)ethene (p,p'-DDE) are known to induce CYP3A4 activity through activation of nuclear receptors, such as the pregnane X receptor. However, this induction of CYP3A4 has not yet been investigated in humans. Thus, the aim of the study was to determine the variability of the CYP3A4 phenotype in regard to increased concentrations of PCBs and other persistent organohalogen pollutants (POPs) in healthy Faroese adults. In 3 10 randomly selected Faroese residents aged 18-60 years, the CYP3A4 activity was determined based on the urinary 6 beta-hydroxycortisol/cortisol (6 beta-OHC/FC) ratio. POP exposures were assessed by measuring their concentrations in serum lipid. The results showed a unimodal distribution of the 6 beta-OHC/FC ratio with values ranging from 0.58 to 27.38. Women had a slightly higher 6 beta-OHC/ FC ratio than men (p=0.07). Confounder-adjusted multiple regression analysis showed significant associations between 6 beta-OHC/FC ratios and Sigma PCB, PCB-TEQ and p,p'-DDE, o,p'-DDT and HCB, respectively, but the associations were statistically significant for men only. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 50 条
  • [31] Effect of Moxidectin on CYP3A4 Activity as Evaluated by Oral Midazolam Pharmacokinetics in Healthy Subjects
    Korth-Bradley, Joan M.
    Parks, Virginia
    Wagner, Frank
    Chalon, Stephan
    Gourley, Ian
    Matschke, Kyle
    Gossart, Sophie
    Ripp, Sharon L.
    Fleckenstein, Lawrence
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2014, 3 (02): : 151 - 157
  • [32] Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test
    Hutson, Paul R.
    Oettel, Kurt
    Douglas, Jeff
    Ritter, Mark
    Messing, Ed
    Staab, Mary Jane
    Alberti, Dona
    Horvath, Dorthea
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (03) : 373 - 377
  • [33] Drug-Drug Interaction Studies to Evaluate the Effect of Inhibition of UGT1A1 and CYP3A4 and Induction of CYP3A4 on the Pharmacokinetics of Tropifexor in Healthy Subjects
    Chen, Jin
    Stringer, Rowan
    Shah, Bharti
    Gu, Jessie
    Zhang, Yiming
    Hackling, Melissa
    Prince, William
    Woessner, Ralph
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (11): : 1253 - 1263
  • [34] Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans
    Perera, M. A.
    Thirumaran, R. K.
    Cox, N. J.
    Hanauer, S.
    Das, S.
    Brimer-Cline, C.
    Lamba, V.
    Schuetz, E. G.
    Ratain, M. J.
    Di Rienzo, A.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (01): : 49 - 60
  • [35] Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans
    M A Perera
    R K Thirumaran
    N J Cox
    S Hanauer
    S Das
    C Brimer-Cline
    V Lamba
    E G Schuetz
    M J Ratain
    A Di Rienzo
    The Pharmacogenomics Journal, 2009, 9 : 49 - 60
  • [36] Effect of NIPRISAN® on CYP3A4 activity in vitro
    Bulus Adzu
    Collen Masimirembwa
    Kudirat Bola Mustapha
    Roslyn Thelingwani
    Rukaiyatu Abdullahi Kirim
    Karniyus Shingu Gamaniel
    European Journal of Drug Metabolism and Pharmacokinetics, 2015, 40 : 115 - 118
  • [37] Genetic epidemiology of induced CYP3A4 activity
    Rahmioglu, Nilufer
    Heaton, James
    Clement, Gail
    Gill, Raj
    Surdulescu, Gabriela
    Zlobecka, Karolina
    Hodgkiss, Dylan
    Ma, Yongmin
    Hider, Robert C.
    Smith, Norman W.
    Ahmadi, Kourosh R.
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (10): : 642 - 651
  • [38] Influenza immunization and CYP3A4 activity.
    Hayney, MS
    Hammes, RJ
    Fine, JP
    Bianco, JA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P16 - P16
  • [39] Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test
    Paul R. Hutson
    Kurt Oettel
    Jeff Douglas
    Mark Ritter
    Ed Messing
    Mary Jane Staab
    Dona Alberti
    Dorthea Horvath
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 373 - 377
  • [40] PREDICTION OF CYP3A4 INDUCTION POTENTIAL WITH RIS IN HEPARG™ CELLS AT MRNA AND ACTIVITY LEVELS
    Sun, Jun
    Shebley, Mohamad
    Lau, Yau Yi
    de Morais, Sonia
    Rajaraman, Ganesh
    DRUG METABOLISM REVIEWS, 2014, 45 : 79 - 80